talipexole has been researched along with Kidney Failure, Chronic in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, M | 1 |
| Inoue, Y | 1 |
| Namba, K | 1 |
| Munezawa, T | 1 |
| Matsuura, M | 1 |
1 other study available for talipexole and Kidney Failure, Chronic
| Article | Year |
|---|---|
Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Topics: Adult; Age of Onset; Aged; Anticonvulsants; Azepines; Clonazepam; Dopamine Agents; Female; Humans; K | 2008 |